Abstract: An antithrombogenic thermoplastic polyurethane product and process for preparing the same which comprises a substrate and at least one layer of a polyurethane alloy complex comprising a thermoplastic polyurethane and completely dispersed therein a preformed complex of an antithrombogenic material ionically bonded with a quaternary ammonium compound.

Abstract: A polymer admixture is formed from a base polymer and thermoplastic copolymer additive including polar hard segments and polar and nonpolar soft blocks in graft or block copolymer form. The polymer admixture is characterized by increased contact angle hysteresis and is formed into blood and tissue-contacting surfaces of a biomedical device or into textiles. A preferred additive comprises a segmented block copolymer having polydialkylsiloxanes as nonpolar soft blocks, and a polyurethane as hard segments and a polyalkylene oxide as a polar soft block.

Abstract: A stable polymer emulsion composition capable of giving a thromboresistant surface, said composition comprising polyurethane, a polydiorganosiloxane, and a cyclic ether, said polydiorganosiloxane being dispersed as particles having an average particle diameter of 0.1 to 50 microns in a solution of the polyurethane in the cyclic ether, and at least a part of the surfaces of said particles being crosslinked. The said composition can be prepared by dispersing a polydiorganosiloxane having a hydroxyl or acetate end group as fine particles in a solution of polyurethane in a cyclic ether to form an emulsion, and reacting the polydiorganosiloxane with a crosslinking agent to crosslink at least a part of the surfaces of the particles in the presence of 10 to 500 ppm of water.

Abstract: An antithrombogenic polyurethane polymer being bound to a support substrate wherein the antithrombogenic agent is reacted through an aldehyde group with an amine functionality of a polyurethane-urea to form the covalently bonded antithrombogenic material.

Abstract: A medical implant useful in the regeneration of soft and hard connective tissue, such as cartilage and bone, is disclosed which comprises a copolymer of a major amount of epsilon caprolactone and a minor amount of lactide. Where regeneration of bone tissue, in particular, is desired, the copolymer may further include osteogenic material in powdered or particulate form. If soft tissue regeneration is desired, the copolymer may include chopped carbon fiber. A mass of the copolymer, optionally including additives, may be molded by hand by heating the polymer to a temperature of 115.degree.-160.degree. F., by, for example, immersion in hot water. The mass is then molded to the void to be filled or shape the regenerated tissue is desired to assume, and implanted in the patient. The mass is gradually replaced by regenerated tissue.

Abstract: This invention relates to novel radiopaque resin compositions, and to medical-surgical tubings prepared therefrom. More particularly, the invention pertains to compositions of polyiodobenzoic acid ester-containing polyvinyl resins and a platinum-cured silicone network polymer dispersed therein and their use in medical-surgical devices, especially tubing and catheters.

Abstract: This invention relates to catheters prepared from novel radiopaque resin compositions and medical-surgical tubings. More particularly, the invention pertains to compositions of polyiodobenzoic acid ester-containing polyurethane resins, alone, or in combination with vinyl resins, and a platinum-cured silicone network polymer dispersed therein and their use in medical-surgical devices, especially tubing and catheters.

Abstract: This invention relates to novel radiopaque resin compositions, and to medical-surgical tubings and catheters prepared therefrom. More particularly, the invention pertains to compositions of polyiodobenzoic acid ester-containing polyvinyl resins and a platinum-cured silicone network polymer dispersed therein and their use in medical-surgical devices, especially tubing and catheters.

Abstract: This invention provides tubings formed of a polymeric composition comprising a thermoplastic elastomeric hydrocarbon black copolymer and a polysiloxane having a kinematic viscosity of 20 to 10.sup.6 centistokes at room temperature, the polysiloxane constituting from about 0.1 to 12 percent by weight of the composition. The tubings can be used in medical applications.

Abstract: Articles having reduced thrombogenicity when in contact with blood products containing albumin and methods of their use are provided. The articles comprise at the surface of blood contact a water insoluble polymeric substrate material having covalently attached thereon aliphatic extensions of 14 to 20 carbon units. When exposed to blood the aliphatic chain extensions provide a hydrophobic binding site for albumin. The articles when implemented with whole blood or blood products selectively enhance albumin affinity binding to the exclusion of other blood components, and subsequently minimize thrombus formation.

Abstract: Antithrombogenic polyurethane polymers having the antithrombogenic material covalently bound to the polyurethane.

Abstract: A method of storing blood components uses a blood component storage container which is made of a plasticized polyvinyl chloride formulation which includes a heat stabilizer system selected from the group consisting of salts of C.sub.10 to C.sub.26 saturated fatty acids present in an amount of less than about one percent by weight of the composition. Surprisingly, use of only minimal amounts of these higher molecular weight fatty acids results in an effectively heat stabilized product suited for mass production techniques. As a result, the total amount of the heat stabilizer which can possibly leach into blood plasma is significantly reduced. The material from which the container is made preferably includes an effective amount of a plasticizer which is also essentially nonextractable in blood plasma.

Abstract: Polymer compositions of a mixture of vinyl chloride polymer and polyurethane with tertiary amine and/or ammonium groups and heparin.

Abstract: A thermoplastic material formed from a hydrocarbon chain is modified to inhibit the production of static charges. The thermoplastic material may be a polypropylene. A weak salt having properties of ionizing and having its positive ions bond chemically to the thermoplastic material is mixed in the thermoplastic material. A chemical agent is also dispersed in the thermoplastic material and is provided with properties of facilitating the dispersion of the positive ions of the weak salt throughout the thermoplastic material for chemical bonding to the thermoplastic material. The chemical agent may also be bonded chemically to the thermoplastic material. The weak salt may be cupric acetate and the chemical agent may be an ethoxylated amine when the thermoplastic material is polypropylene. The polypropylene is preferably mixed with a suitable material such as polyethylene to enhance the amorphous characteristics of the thermoplastic material.

Abstract: Embedding mass of polyurethane produced on the basis of castor oil, and a method for its production, wherein an aromatic diisocyanate is reacted with a mixture of castor oil and trimethylolpropane into an NCO-group displaying pre-adduct, the pre-adduct being mixed for network polymerization with castor oil or a mixture of castor oil and trimethylolpropane, and after embedding the mixture is hardened in the presence of catalyst, thereby characterized in that a titanium alkylate compound is used as catalyst in amounts from 7 to 700 ppm, calculated as elemental titanium. Preferably, the catalyst is a titanium tetraalkylate; in particular titanium tetrabutylate. Also, a titanium magnesium hexaalkylate may be used as titanium alkylate compound; preferably, titanium magnesium hexabutylate. Preferably the catalyst is present in amounts from 40 to 140 ppm, calculated as elemental titanium.

Abstract: A process for producing an antithrombogenic vinyl acetate polymer or a hydrolyzate thereof which comprises treating the vinyl acetate polymer or hydrolyzate with a solution of a fibrinolytic enzyme so as to fix the fibrinolytic enzyme to the polymer. The resulting antithrombogenic vinyl acetate polymer or hydrolyzate is advantageously used in a material which comes into contact with the blood in use and is especially useful in a surgical tube.

Abstract: Fibres for biological uses can be produced by adding to a spinnable solution of a polymer selected from among many of the most common polymers and copolymers, a substance selected from among anti-platelet aggregation substances, anticoagulants and substances having a similar action. The substances can also be applied as a surface outer layer to articles made with the polymeric substances.

Abstract: The disclosure is of articles having reduced thrombogenicity and which are useful for purposes requiring their contact with whole blood. The articles comprise solid, polymeric resin substrates to which there is fixed a compound of the formula: ##STR1## wherein R.sub.1 is alkyl of 12 to 18 carbon atoms, inclusive; R.sub.2, R.sub.3 and R.sub.4 are each independently selected from the group consisting of hydrogen and lower alkyl; X represents a negative monovalent ion such as halogen; and A represents the residue of a salt of heparin after removal of the positive ion. The articles advantageously exhibit low toxicity and excellent blood compatibility when used for purposes which bring them into contact with whole blood for prolonged periods of time.

Abstract: Potting media based on polyurethanes produced with castor oil, a process for their preparation as well as their use. To at least one of the ingredients of the potting medium is added a dialkyltin compound in an amount resulting in a content of from about 5 to 50 ppm, calculated as elementary tin, of the dialkyltin compound. A diisocyanate based on a carbon ring compound in stoichiometric excess is reacted with a mixture of castor oil and trimethylolpropane to a prepolymer having NCO-groups. Then the prepolymer is mixed with castor oil or a mixture of castor oil and trimethylolpropane for crosslinking. Preferred diisocyanates are aromatic diisocyanates having up to about 30 carbon atoms.The potting media exhibit a favorable course of the viscosity, wet excellently and distribute very rapidly and are particularly suited for the embedding of membranes.

Abstract: A non-wicking polyurethane casting system has been developed which comprises the reaction product obtained by admixing a polyol containing N-N-N'-N'-tetrakis (2-hydroxypropyl) ethylene diamine, (hereafter referred to as QUADROL) with an isocyanate terminated polyurethane based prepolymer. This non-wicking casting system is useful as a potting compound in biomedical applications such as dialysis and hemoultrafiltration devices and the like.